Vanguard Capital Management »

Aytu Biopharma shares owned by Vanguard Capital Management

Quarter-by-quarter ownership of Aytu Biopharma (AYTU) shares owned by Vanguard Capital Management from 13F filings

Historical chart of Vanguard Capital Management investment in Aytu Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Aytu Biopharma held by Vanguard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aytu Biopharma by Vanguard Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $713k 261k 2.73

More positions owned by Vanguard Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)

View all positions for Vanguard Capital Management

Top funds holding Aytu Biopharma

Nantahala Capital Management
Stonepine Capital Management
AWM Investment Company
Diadema Partners
Vanguard Group
Vanguard Capital Management
Crown Advisors Management
Two Sigma Investments
Persistent Asset Partners
Geode Capital Management
Renaissance Technologies
Vanguard Fiduciary Trust
Dimensional Fund Advisors
Citadel Advisors
XTX Topco

View all funds holding Aytu Biopharma